RIL
KALV

Rothschild Investment LLC’s KalVista Pharmaceuticals KALV Stock Holding History

Rothschild Investment LLC’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.21K Buy
110
+40
+57% +$645 ﹤0.01% 2510
2025
Q4 		$1.13K Sell
70
-50
-42% -$662 ﹤0.01% 2628
2025
Q3 		$1.46K Sell
120
-20
-14% -$276 ﹤0.01% 2412
2025
Q2 		$1.58K Buy
140
+35
+33% +$428 ﹤0.01% 2208
2025
Q1 		$1.21K Buy
105
+90
+600% +$919 ﹤0.01% 2227
2024
Q4 		$127 Sell
15
-25
-63% -$259 ﹤0.01% 2880
2024
Q3 		$463 Buy
40
+30
+300% +$377 ﹤0.01% 2491
2024
Q2 		$118 Buy
+10
New +$117 ﹤0.01% 2680

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rothschild Investment LLC's KALV Position: Q1 2026 in Review

Rothschild Investment LLC increased its KalVista Pharmaceuticals (KALV) stake by 57% in Q1 2026, buying an estimated $645 and bringing the position to 110 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #2510.

Rothschild Investment LLC first reported a position in KALV in Q2 2024 and has held it in 8 quarters since. 183 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Rothschild Investment LLC held 110 shares of KalVista Pharmaceuticals worth $2.21K as of Q1 2026.
  • Rothschild Investment LLC bought 40 KalVista Pharmaceuticals shares in Q1 2026, an estimated $645.
  • KalVista Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2510 holding.
  • Rothschild Investment LLC first reported a position in KalVista Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
  • 183 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.